-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Initiates Coverage On Camp4 Therapeutics with Strong Buy Rating, Announces Price Target of $10

Benzinga·10/23/2026 11:17:14
Listen to the news
Raymond James analyst Tiago Fauth initiates coverage on Camp4 Therapeutics (NASDAQ:CAMP) with a Strong Buy rating and announces Price Target of $10.